To address the nationwide shortage of medications for attention-deficit/hyperactivity disorder, the Drug Enforcement Administration is allowing an increase in the ...

The stimulant shortage reveals critical gaps in ADHD treatment, especially for adults, with rising diagnoses and limited clinical guidance complicating care. Despite increased production quotas, ...

In a significant move to mitigate the ongoing shortage of ADHD medications in the U.S., the Drug Enforcement Administration (DEA) has authorized a substantial increase in the production limits for ...

One pharmaceutical manufacturer is recalling lots of generic Vyvanse over failed dissolution tests. Medication may not be ...

Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these ...

Co announces it has submitted a supplemental New Drug Application to the FDA for VYVANSE (lisdexamfetamine dimesylate) for the treatment of Attention Deficit Hyperactivity Disorder in adults. This ...

More than a year after the Food and Drug Administration announced a nationwide shortage of Adderall, doctors and patients say they are still struggling to get their hands on ADHD medications. Despite ...

Higher doses of commonly prescribed ADHD medications may increase the risk of psychosis, a new study has found Getty High doses of commonly prescribed medications for ADHD have been linked to an ...

NEW YORK, April 30 (UPI) --Despite available treatments, attention-deficit/hyperactivity disorder, or ADHD, often goes undetected in adults, wreaking havoc on their ...

Mission Prep has released a new guide for parents considering Vyvanse as a treatment for teens with ADHD. The document covers ...